Latest Genovis News & Updates

See the latest news and media coverage for Genovis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Genovis

Biotechnology company providing biopharmaceutical research tools

genovis.com
Headquarters
Kävlinge, Sweden
Founded year
1999
Company type
Public company
Number of employees
10–50
Industry
Biotechnology & Medical Research

Last updated

Latest news about Genovis

In short: Genovis achieved strong financial growth, expanded its proteomics and genomics portfolio through acquisitions, and secured major licenses.

Company announcements

Genovis

Genovis reports 4% net sales growth for Q1 2026

Net sales reached SEK 33,506 thousand. EBITDA improved to SEK 9,510 thousand. Launched LysCERATOR™ and SEQguard™. Signed ADC license deal.

Unlock all announcements with a

Media coverage

Marketscreener

Genovis AB Stock

Sep. 07 Synact surged in Stockholm, the OMXS30 index rose 0.2 percent FW ...

The Wall Street Journal

Genovis AB Series B

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

The Wall Street Journal

Genovis AB Series B

kr 20.95 SEK-0.05-0.24% ...

Unlock all articles with a

Never miss news about Genovis

Track Genovis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Genovis competitors & trending companies

Browse news for competitors to Genovis and other trending companies.